Document is current
Any future updates will be listed below
-
Authors
Pérez-Escurza, Oihane https://orcid.org/0000-0002-6966-4337
Flores-Montero, Juan https://orcid.org/0000-0002-1119-4387
Óskarsson, Jón Þórir https://orcid.org/0000-0002-9201-1166
Sanoja-Flores, Luzalba https://orcid.org/0000-0002-9275-7793
del Pozo, Julio
Lecrevisse, Quentin https://orcid.org/0000-0001-8715-5846
Martín, Silvia
Reed, Elín Ruth
Hákonardóttir, Guðlaug Katrín
Harding, Stephen
Þorsteinsdóttir, Sigrún https://orcid.org/0000-0001-5017-3530
Rögnvaldsson, Sæmundur
Love, Thorvardur Jon
Durie, Brian
Kristinsson, Sigurður Yngvi https://orcid.org/0000-0002-4964-7476
Orfao, Alberto https://orcid.org/0000-0002-0007-7230
- License Information
-
More Information
Article History
Received: 17 July 2023
Revised: 26 October 2023
Accepted: 3 November 2023
First Online: 11 December 2023
Competing interests
: JF-M and AO are inventors of the EuroFlow-owned patents PCT/NL2010/050332 (Methods, reagents, and kits for flow cytometric immunophenotyping of normal, reactive and malignant leukocytes) and PCT/NL20 13/050420 (Methods, reagents and kits for detecting minimal residual disease), licensed to BD Biosciences (San José, CA, USA) which pay royalties to the EuroFlow Consortium. These royalties are exclusively used for continuation of the EuroFlow collaboration and sustainability of the EuroFlow Consortium. SYK has received research funding from Amgen and Celgene. SH is currently employed by The Binding Site. OP-E, JÞO, LS-F, JP, QL, SM, ERR, GKH, and BD declare no conflict of interest.
